About Health X Platform Limited
Data last updated:
Health X Platform Limited is a public limited company based in Kolkata, West Bengal, India. It operates in the financial holding companies segment of the financial services sector. It was incorporated on 06 June 1989 and has been in existence for over 37 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN L65993WB1989PLC047002. Its GSTIN is 19AADCS7147N1ZP (West Bengal). It is a listed company as per MCA records. Its shares are listed on BSE: 533259 and NSE: HEALTHX.
The company has an authorised share capital of ₹35.53 Cr and a paid-up capital of ₹31.81 Cr. It was formerly known as Microsec Financial Services Private Limited and Microsec Financial Services Limited. It is led by directors including Banwari Lal Mittal (Managing Director) and Jayanta Nath Mukhopadhyaya.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Azimganj House 2nd Floor 7 Abanindra Nath Thakur Sarani (Formerly Camac Street), Kolkata, West Bengal, India – 700017.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹1,319.27 Cr, a growth of 13.9% compared to the previous year. For the same year it recorded a net profit of ₹1.92 Cr (net margin 0.1%) and EBITDA of -₹53.24 Cr (EBITDA margin -4%). The net worth stands at ₹640.89 Cr (down 4.3% YoY). Total assets are valued at ₹790.93 Cr (down 8.6% YoY).
The company has about 1 employee on its provident fund (EPFO) records. Its group structure includes 9 subsidiaries.
The company is associated with 2 brands: Microsec and Sastasundar Ventures. As per MCA filings, the company has satisfied charges of ₹39 Cr on record. Court records list 21 cases involving the company, including 21 filed by the company; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sastasundarventures.com.
Company details
Name history
Health X Platform has undergone 3 name changes throughout its history. The company was previously known as Microsec Financial Services Private Limited, Microsec Financial Services Limited, and Health X Platform Limited. The current legal name is Health X Platform Limited.
| Company Name | Status |
|---|---|
| Health X Platform Limited | Current |
| Microsec Financial Services Private Limited | Previous |
| Microsec Financial Services Limited | Previous |
CIN history
Health X Platform has one previous CIN (Corporate Identification Number): U65993WB1989PLC047002. The current CIN is L65993WB1989PLC047002, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L65993WB1989PLC047002 | Current |
| U65993WB1989PLC047002 | Previous |
Contact details
Health X Platform Limited's registered office is in Kolkata, West Bengal. Its website is sastasundarventures.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressAzimganj House 2nd Floor 7 Abanindra Nath Thakur Sarani (Formerly Camac Street), Kolkata, West Bengal, India – 700017
- IndustryFinancial Services, Financial Holding Companies
To see the full contact details of Health X Platform Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Health X Platform operates two associated brands: Microsec and Sastasundar Ventures. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Diversified investment and wealth management services are offered by Microsec. | microsec.in | |
| Online digital platform for medical services and counselling | sastasundarventures.com |
Business activity
The main business activity of Health X Platform is financial and insurance service. In detail, this covers other financial activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| K | Financial and insurance Service | K8 | Other financial activities |
To see the full business activity and turnover split of Health X Platform Limited, buy the company report.
Financials of Health X Platform Limited
FY 2025-26 filings availableHealth X Platform Limited reported revenue of ₹1,319.27 Cr (up 13.9% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1,319 | 1,159 | 1,432 | 1,060 | 1,798 | 551 | 388 |
| Revenue growth | +13.9% | -19.1% | +35.1% | -41.0% | +226.5% | +42.0% | - |
| EBITDA | (53.24) | (211) | (24.38) | (115) | 1,114 | (10.26) | (52.20) |
| EBITDA margin | -4.0% | -18.2% | -1.7% | -10.9% | +62.0% | -1.9% | -13.5% |
| Profit before tax | (2.35) | (204) | (30.51) | (122) | 1,109 | (16.36) | (57.57) |
| Net profit | 1.92 | 90.97 | 8.82 | (65.43) | (287) | (10.42) | (39.05) |
| Net profit margin | +0.2% | +7.9% | +0.6% | -6.2% | -16.0% | -1.9% | -10.1% |
| EPS (₹) | 0.37 | (28.66) | 2.79 | (22.70) | 197.04 | (3.27) | (12.20) |
| Balance sheet | |||||||
| Total assets | 791 | 865 | 1,003 | 1,003 | 1,096 | 242 | 254 |
| Net worth | 641 | 670 | 762 | 753 | 826 | 200 | 210 |
| Total debt | 25.65 | 0.92 | 3.88 | 9.33 | 1.85 | 12.50 | 7.85 |
| Cash & bank | 30.22 | 12.44 | 46.66 | 195 | 212 | 12.80 | 18.27 |
| Net working capital | 137 | 162 | 276 | 465 | 440 | 79.83 | 75.75 |
| Cash flow | |||||||
| Cash from operations | (73.83) | (17.31) | 35.86 | (112) | (207) | (30.51) | (69.24) |
| Cash from investing | 171 | (1.13) | (33.93) | 133 | 220 | 21.37 | (22.13) |
| Cash from financing | (79.59) | (0.44) | (2.35) | (1.83) | (11.42) | 3.73 | 103 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 447 | 374 | 346 | 301 | 298 | 286 | 281 | 274 |
| Revenue growth (YoY) | +49.7% | +30.8% | +22.9% | +10.2% | +10.4% | - | - | - |
| Other income | 12.83 | 13.76 | 13.62 | 5.51 | 25.38 | 21.91 | (11.83) | 22.29 |
| EBITDA | (8.37) | (26.16) | (10.36) | (22.79) | 6.06 | (25.19) | (25.93) | (194) |
| EBITDA margin | -1.9% | -7.0% | -3.0% | -7.6% | +2.0% | -8.8% | -9.2% | -71.1% |
| Depreciation | 1.89 | 1.94 | 2.17 | 1.33 | 1.17 | 1.34 | 1.43 | 1.45 |
| Interest | 0.59 | 0.49 | 0.17 | 0.04 | 0.09 | 0.01 | 0.05 | 0.06 |
| Profit before tax | 1.98 | (14.83) | 0.92 | (18.65) | 30.18 | (4.63) | (39.24) | (174) |
| Tax | (0.01) | (1.85) | 0.55 | (3.20) | 3.59 | (22.20) | 0.78 | (22.87) |
| Net profit | 1.99 | (12.98) | 0.37 | (15.45) | 26.59 | 17.57 | (40.02) | (151) |
| EPS (₹) | 0.80 | (3.51) | 0.35 | (3.99) | 7.52 | 4.30 | (8.47) | (34.40) |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 0.38 | 0.44 | 0.45 | 0.25 | 0.19 | 0.28 | 0.31 |
| Revenue growth | -13.6% | -2.2% | +80.0% | +31.6% | -32.1% | -9.7% | - |
| EBITDA | (1.18) | (1.35) | (1.47) | (1.16) | (0.86) | (0.64) | (1.03) |
| EBITDA margin | -310.5% | -306.8% | -326.7% | -464.0% | -452.6% | -228.6% | -332.3% |
| Profit before tax | (0.96) | (0.72) | (0.88) | 0.65 | (0.35) | (0.16) | 0.63 |
| Net profit | (0.96) | (0.73) | (0.88) | (0.60) | (0.41) | (0.16) | (0.66) |
| Net profit margin | -252.6% | -165.9% | -195.6% | -240.0% | -215.8% | -57.1% | -212.9% |
| EPS (₹) | (0.30) | (0.22) | (0.28) | 0.20 | (0.12) | (0.04) | 0.20 |
| Balance sheet | |||||||
| Total assets | 271 | 272 | 273 | 273 | 273 | 273 | 273 |
| Net worth | 271 | 272 | 273 | 273 | 273 | 273 | 273 |
| Total debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash & bank | 0.08 | 0.05 | 0.11 | 0.22 | 0.20 | 0.18 | 0.22 |
| Net working capital | 0.73 | 0.93 | 5.64 | 5.69 | 4.71 | 0.58 | 0.44 |
| Cash flow | |||||||
| Cash from operations | 0.04 | (5.51) | (1.21) | (0.63) | (0.52) | (0.51) | (0.83) |
| Cash from investing | (0.01) | 5.45 | 1.09 | 0.64 | 0.54 | 0.47 | 0.97 |
| Cash from financing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.08 | 0.09 | 0.09 | 0.10 | 0.10 | 0.10 | 0.11 | 0.11 |
| Revenue growth (YoY) | -20.0% | -10.0% | -18.2% | -9.1% | +25.0% | - | - | - |
| Other income | 0.01 | 0.10 | 0.01 | 0.01 | 0.26 | 0.20 | 0.19 | 0.19 |
| Total expenses | 0.59 | 0.32 | 0.49 | 0.37 | 0.38 | 0.34 | 0.38 | 0.59 |
| EBITDA | (0.51) | (0.23) | (0.40) | (0.27) | (0.28) | (0.24) | (0.27) | (0.48) |
| EBITDA margin | -637.5% | -255.6% | -444.4% | -270.0% | -280.0% | -240.0% | -245.5% | -436.4% |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (0.52) | (0.15) | (0.41) | (0.28) | (0.10) | (0.06) | (0.10) | (0.31) |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 447 | 374 | 346 | 301 | 298 | 286 | 281 | 274 |
| Revenue growth (YoY) | +49.7% | +30.8% | +22.9% | +10.2% | +10.4% | - | - | - |
| Other income | 12.83 | 13.76 | 13.62 | 5.51 | 25.38 | 21.91 | (11.83) | 22.29 |
| EBITDA | (8.37) | (26.16) | (10.36) | (22.79) | 6.06 | (25.19) | (25.93) | (194) |
| EBITDA margin | -1.9% | -7.0% | -3.0% | -7.6% | +2.0% | -8.8% | -9.2% | -71.1% |
| Depreciation | 1.89 | 1.94 | 2.17 | 1.33 | 1.17 | 1.34 | 1.43 | 1.45 |
| Interest | 0.59 | 0.49 | 0.17 | 0.04 | 0.09 | 0.01 | 0.05 | 0.06 |
| Profit before tax | 1.98 | (14.83) | 0.92 | (18.65) | 30.18 | (4.63) | (39.24) | (174) |
| Tax | (0.01) | (1.85) | 0.55 | (3.20) | 3.59 | (22.20) | 0.78 | (22.87) |
| Net profit | 1.99 | (12.98) | 0.37 | (15.45) | 26.59 | 17.57 | (40.02) | (151) |
| EPS (₹) | 0.80 | (3.51) | 0.35 | (3.99) | 7.52 | 4.30 | (8.47) | (34.40) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,319 | 1,159 | 1,432 | 1,060 | 1,798 | 551 | 388 |
| Revenue growth | +13.9% | -19.1% | +35.1% | -41.0% | +226.5% | +42.0% | - |
| Other income | 58.27 | 13.46 | 4.08 | 3.07 | 2.82 | 0.98 | 0.99 |
| Total expenses | 1,373 | 1,370 | 1,456 | 1,176 | 684 | 561 | 440 |
| Employee cost | 0.00 | 49.79 | 49.02 | 45.35 | 43.94 | 29.13 | 28.45 |
| EBITDA | (53.24) | (211) | (24.38) | (115) | 1,114 | (10.26) | (52.20) |
| EBITDA margin | -4.0% | -18.2% | -1.7% | -10.9% | +62.0% | -1.9% | -13.5% |
| Depreciation | 6.60 | 5.83 | 9.14 | 8.20 | 4.16 | 4.47 | 4.90 |
| Interest | 0.78 | 0.29 | 1.07 | 1.94 | 3.34 | 2.61 | 1.46 |
| Profit before tax | (2.35) | (204) | (30.51) | (122) | 1,109 | (16.36) | (57.57) |
| Tax | (0.91) | (70.12) | (36.36) | (22.78) | 244 | 0.72 | (5.43) |
| Net profit | 1.92 | 90.97 | 8.82 | (65.43) | (287) | (10.42) | (39.05) |
| Net profit margin | +0.2% | +7.9% | +0.6% | -6.2% | -16.0% | -1.9% | -10.1% |
| EPS (₹) | 0.37 | (28.66) | 2.79 | (22.70) | 197.04 | (3.27) | (12.20) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 |
| Reserves & surplus | 609 | 638 | 726 | 717 | 790 | 163 | 173 |
| Shareholders' funds (net worth) | 641 | 670 | 762 | 753 | 826 | 200 | 210 |
| Minority interest | 124 | 195 | 237 | 240 | 268 | 29.48 | 36.10 |
| Secured loans | 22.09 | 0.00 | 0.00 | 0.00 | 0.00 | 9.79 | 5.01 |
| Unsecured loans | 3.56 | 0.92 | 3.88 | 9.33 | 1.85 | 2.71 | 2.84 |
| Total debt | 25.65 | 0.92 | 3.88 | 9.33 | 1.85 | 12.50 | 7.85 |
| Total liabilities | 791 | 865 | 1,003 | 1,003 | 1,096 | 242 | 254 |
| Assets | |||||||
| Gross block | 155 | 139 | 143 | 132 | 111 | 126 | 124 |
| Net block | 117 | 102 | 110 | 107 | 93.42 | 110 | 114 |
| Capital work in progress | 1.20 | 10.24 | 0.35 | 0.99 | 0.42 | 0.08 | 0.01 |
| Investments | 519 | 575 | 676 | 513 | 666 | 43.42 | 55.77 |
| Inventories | 145 | 110 | 116 | 181 | 114 | 77.18 | 77.09 |
| Sundry debtors | 7.66 | 9.98 | 34.79 | 35.08 | 21.20 | 13.56 | 14.96 |
| Cash & bank balances | 30.22 | 12.44 | 46.66 | 195 | 212 | 12.80 | 18.27 |
| Loans & advances | 93.56 | 134 | 157 | 164 | 161 | 26.93 | 26.86 |
| Total current assets | 276 | 267 | 354 | 575 | 508 | 130 | 137 |
| Total current liabilities | 139 | 105 | 78.54 | 110 | 68.04 | 50.64 | 61.43 |
| Net working capital | 137 | 162 | 276 | 465 | 440 | 79.83 | 75.75 |
| Total assets | 791 | 865 | 1,003 | 1,003 | 1,096 | 242 | 254 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 12.42 | 31.31 | 31.72 | 13.01 | 12.04 | 17.45 | 6.31 |
| Net cash from operating activities | (73.83) | (17.31) | 35.86 | (112) | (207) | (30.51) | (69.24) |
| Net cash from investing activities | 171 | (1.13) | (33.93) | 133 | 220 | 21.37 | (22.13) |
| Net cash from financing activities | (79.59) | (0.44) | (2.35) | (1.83) | (11.42) | 3.73 | 103 |
| Net change in cash | 17.77 | (18.89) | (0.41) | 18.72 | 0.96 | (5.41) | 11.14 |
| Closing cash | 30.22 | 12.44 | 46.66 | 195 | 212 | 12.80 | 18.27 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +13.9% | -19.1% | +35.1% | -41.0% | +226.5% | +42.0% | - |
| EBITDA growth | +74.8% | -765.5% | +78.8% | -110.3% | - | +80.3% | - |
| PBT growth | +98.9% | -567.5% | +75.1% | - | +9998.0% | +71.6% | -37.9% |
| Net income growth | -97.9% | +931.4% | +113.5% | +77.2% | -2658.6% | +73.3% | - |
| Revenue CAGR (3Y) | +7.6% | -13.6% | +37.5% | +39.8% | +100.9% | +50.4% | +42.2% |
| EBITDA CAGR (3Y) | -22.7% | - | +33.4% | +30.2% | - | -6.9% | +37.6% |
| Profitability & leverage | |||||||
| Net income margin | -0.1% | -11.5% | +0.4% | -9.4% | +48.1% | -3.1% | -13.4% |
| Return on capital employed | - | -1.7% | -3.9% | -15.1% | -8.6% | 0.0% | 0.0% |
| Return on net worth | - | +6.8% | +0.8% | -12.6% | -9.6% | 0.0% | 0.0% |
| Debt / equity | - | 0.00 | 0.01 | 0.01 | 0.01 | 0.05 | 0.03 |
| Long-term debt / equity | - | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 |
| Interest cover | -1.30 | -0.13 | -3.19 | -1.57 | 0.30 | -17.72 | -2.56 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 8.33 | 10.46 | 8.75 | 15.20 | 4.41 | 3.15 |
| Inventory turnover | - | 10.37 | 9.68 | 7.23 | 18.88 | 7.15 | 7.09 |
| Debtors turnover | - | 52.36 | 41.11 | 37.79 | 103.60 | 38.68 | 34.05 |
| EPS (₹) | 0.37 | (28.66) | 2.79 | (22.70) | 197.04 | (3.27) | (12.20) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 210.58 | 238.09 | 235.27 | 258.25 | 61.27 | 64.48 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.08 | 0.09 | 0.09 | 0.10 | 0.10 | 0.10 | 0.11 | 0.11 |
| Revenue growth (YoY) | -20.0% | -10.0% | -18.2% | -9.1% | +25.0% | - | - | - |
| Other income | 0.01 | 0.10 | 0.01 | 0.01 | 0.26 | 0.20 | 0.19 | 0.19 |
| Total expenses | 0.59 | 0.32 | 0.49 | 0.37 | 0.38 | 0.34 | 0.38 | 0.59 |
| EBITDA | (0.51) | (0.23) | (0.40) | (0.27) | (0.28) | (0.24) | (0.27) | (0.48) |
| EBITDA margin | -637.5% | -255.6% | -444.4% | -270.0% | -280.0% | -240.0% | -245.5% | -436.4% |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (0.52) | (0.15) | (0.41) | (0.28) | (0.10) | (0.06) | (0.10) | (0.31) |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.38 | 0.44 | 0.45 | 0.25 | 0.19 | 0.28 | 0.31 |
| Revenue growth | -13.6% | -2.2% | +80.0% | +31.6% | -32.1% | -9.7% | - |
| Other income | 0.38 | 0.76 | 0.73 | 2.00 | 0.72 | 0.68 | 1.87 |
| Total expenses | 1.56 | 1.79 | 1.92 | 1.41 | 1.05 | 0.92 | 1.34 |
| Employee cost | 0.00 | 0.47 | 0.51 | 0.43 | 0.35 | 0.33 | 0.45 |
| EBITDA | (1.18) | (1.35) | (1.47) | (1.16) | (0.86) | (0.64) | (1.03) |
| EBITDA margin | -310.5% | -306.8% | -326.7% | -464.0% | -452.6% | -228.6% | -332.3% |
| Depreciation | 0.10 | 0.10 | 0.10 | 0.16 | 0.18 | 0.17 | 0.18 |
| Interest | 0.06 | 0.03 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 |
| Profit before tax | (0.96) | (0.72) | (0.88) | 0.65 | (0.35) | (0.16) | 0.63 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 | 0.00 |
| Net profit | (0.96) | (0.73) | (0.88) | (0.60) | (0.41) | (0.16) | (0.66) |
| Net profit margin | -252.6% | -165.9% | -195.6% | -240.0% | -215.8% | -57.1% | -212.9% |
| EPS (₹) | (0.30) | (0.22) | (0.28) | 0.20 | (0.12) | (0.04) | 0.20 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 |
| Reserves & surplus | 239 | 240 | 241 | 242 | 241 | 241 | 242 |
| Shareholders' funds (net worth) | 271 | 272 | 273 | 273 | 273 | 273 | 273 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total liabilities | 271 | 272 | 273 | 273 | 273 | 273 | 273 |
| Assets | |||||||
| Gross block | 2.64 | 2.75 | 2.75 | 2.74 | 3.83 | 3.77 | 3.77 |
| Net block | 1.76 | 1.93 | 2.02 | 2.12 | 3.12 | 3.24 | 3.41 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 265 | 265 | 265 | 266 | 265 | 269 | 270 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sundry debtors | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash & bank balances | 0.08 | 0.05 | 0.11 | 0.22 | 0.20 | 0.18 | 0.22 |
| Loans & advances | 0.81 | 1.23 | 5.92 | 5.90 | 4.81 | 0.67 | 0.78 |
| Total current assets | 0.89 | 1.28 | 6.03 | 6.12 | 5.01 | 0.85 | 1.00 |
| Total current liabilities | 0.16 | 0.35 | 0.39 | 0.43 | 0.30 | 0.27 | 0.56 |
| Net working capital | 0.73 | 0.93 | 5.64 | 5.69 | 4.71 | 0.58 | 0.44 |
| Total assets | 271 | 272 | 273 | 273 | 273 | 273 | 273 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.03 | 0.08 | 0.20 | 0.18 | 0.16 | 0.20 | 0.06 |
| Net cash from operating activities | 0.04 | (5.51) | (1.21) | (0.63) | (0.52) | (0.51) | (0.83) |
| Net cash from investing activities | (0.01) | 5.45 | 1.09 | 0.64 | 0.54 | 0.47 | 0.97 |
| Net cash from financing activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net change in cash | 0.03 | (0.06) | (0.11) | 0.02 | 0.02 | (0.04) | 0.14 |
| Closing cash | 0.08 | 0.05 | 0.11 | 0.22 | 0.20 | 0.18 | 0.22 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -13.6% | -2.2% | +80.0% | +31.6% | -32.1% | -9.7% | - |
| EBITDA growth | +12.6% | +8.2% | -26.7% | -34.9% | -34.4% | +37.9% | - |
| PBT growth | -33.3% | +18.2% | - | +9998.0% | -118.8% | - | +10.5% |
| Net income growth | -31.5% | +17.1% | -46.7% | -46.3% | -156.3% | +75.8% | - |
| Revenue CAGR (3Y) | +15.0% | +32.3% | +17.1% | -6.9% | -57.5% | -41.9% | -31.9% |
| EBITDA CAGR (3Y) | +0.6% | +16.2% | +31.9% | +4.0% | - | +10.1% | -21.5% |
| Profitability & leverage | |||||||
| Net income margin | -252.6% | -163.6% | -195.6% | +260.0% | -210.5% | -57.1% | +203.2% |
| Return on capital employed | - | -0.3% | -0.3% | -0.2% | -0.1% | -0.0% | -0.2% |
| Return on net worth | - | -0.3% | -0.3% | -0.2% | -0.1% | -0.1% | -0.2% |
| Debt / equity | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-term debt / equity | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | -4.69 | -2.07 | -2.55 | -2.27 | -2.88 | -3.70 | -2.48 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 0.44 | 0.43 | 0.68 | 0.24 | 0.25 | 0.55 |
| Inventory turnover | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debtors turnover | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS (₹) | (0.30) | (0.22) | (0.28) | 0.20 | (0.12) | (0.04) | 0.20 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 85.45 | 85.67 | 85.95 | 85.76 | 85.90 | 85.95 |
To see the full year-wise statements and ratios of Health X Platform Limited, buy the company report.
Board of directors of Health X Platform Limited
Health X Platform has 6 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Banwari Lal Mittal Also directs: Sastasundar Healthbuddy Limited, Microsec Resources Private Limited, Innogrow Technologies Limited and 5 more | Managing Director | 30 May 2005 | 21 Years 5 Months | Current |
| Jayanta Nath Mukhopadhyaya | Director | 22 Jun 2021 | 5 Years 4 Months | Current |
| Ravi Kant Sharma Also directs: Sastasundar Healthbuddy Limited, Microsec Resources Private Limited, Innogrow Technologies Limited and 1 more | Director | 30 May 2005 | 21 Years 5 Months | Current |
| Abha Mittal | Director | 26 Mar 2015 | 11 Years 7 Months | Current |
| Rupanjana De Also directs: Sastasundar Healthbuddy Limited, Websol Energy System Limited, Mcleod Russel India Limited and 5 more | Director | 15 Sep 2020 | 6 Years 1 Months | Current |
| Anjana Dikshit Also directs: Indobell Insulations Ltd | Director | 10 Nov 2023 | 2 Years 11 Months | Current |
Peer comparison
Health X Platform Limited is compared with the 4 companies closest to it by revenue in the BFSI industry (Healthcare Products, Holding Company), with the same principal business activity (other financial activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Health X Platform Limitedthis company | ₹1,319.27 Cr (FY 2026) | ₹1.92 Cr | 0.1% | 13.9% | 1 | Kolkata, West Bengal, India |
| MGD Holdings Private Limited | ₹1,309.08 Cr (FY 2025) | 2809.0% | Kozhikode, Kerala, India | |||
| BF Investment Limited | ₹1,256.5 Cr (FY 2018) | 23.0% | Pune, Maharashtra, India | |||
| KNRC Holdings and Investments Private Limited | ₹1,053.75 Cr (FY 2025) | 2378.0% | Hyderabad, Telangana, India | |||
| Stock Holding Corporation of India Limited | ₹1,045.39 Cr (FY 2025) | 12.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Health X Platform Limited, buy the company report.
Auditor
Health X Platform Limited is audited by J K V S & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J K V S & CO | FY 2024 | 318086E |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 74.10%, foreign institutional investors hold 2.30%, domestic institutional investors hold 2.60% and retail and other public shareholders hold 21.00%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 74.10% | 74.80% | 74.70% | 74.20% |
| Public | 25.90% | 25.20% | 25.30% | 25.80% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Jan 2016 | 10618526 | Others | ₹21 Cr | Satisfied | |
| 18 Dec 2007 | 10087787 | Hdfc Bank Limited | ₹5 Cr | Satisfied | |
| 17 May 2007 | 10057946 | Hdfc Bank Limited | ₹10 Cr | Satisfied | |
| 17 May 2006 | 80021871 | Hdfc Bank Limited | ₹3 Cr | Satisfied |
To see the full charge records of Health X Platform Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Health X Platform Limited has 21 court cases on record: 21 filed by Health X Platform. 2 cases are pending and 19 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 0 | 2 |
| High courts | 10 | 0 | 0 |
Cases on record (5 of 21)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed by the company against Temptation Foods Ltd. and 8 others | Pending |
| District court, South Twenty Four Parganas, West Bengal | Civil suit | Filed by the company against Venture Business Advisors Pvt.Ltd. | Disposed |
| High Court | Arbitration matter | Filed by the company against Eversight Tradecomm Pvt. Ltd. | Disposed |
| High Court | Arbitration matter | Filed by the company against Temptation Foods Ltd. | Disposed |
| High Court | Arbitration matter | Filed by the company against Stupendors Traders Pvt. Ltd. | Disposed |
To see the full case history of Health X Platform Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Health X Platform Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Health X Platform has 9 subsidiary companies and 1 associated company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Happymate Foods Limited | U15118WB2018PLC226457 | |
| Sastasundar Healthbuddy Limited | U15411WB2011PLC160195 | |
| Retailer Shakti Supply Chain Private Limited | U51100WB2015PTC205351 | |
| Microsec Resources Private Limited | U51109WB1994PTC066509 | |
| Microsec Wealth Management Limited | U65990WB2018PLC224460 | |
| Innogrow Technologies Limited | U72200WB2002PLC094642 |
To see the full group structure of Health X Platform Limited, buy the company report.
Employees & EPFO
Health X Platform Limited has a workforce of 1 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Health X Platform has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AADCS7147N1ZP | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Health X Platform Limited, buy the company report.
Recent activity
Health X Platform Limited has 37 board changes on record since 2005: 22 appointments and 15 cessations. The latest: Parimal Kumar Chattaraj ceased to be Director on 31 Mar 2024.
38 earlier events are in the company report.
News
Frequently asked questions
Health X Platform is an active public limited company based in Kolkata, West Bengal, India. The company works in financial holding companies, within the financial services industry. It was incorporated on 06 June 1989 (37+ years old) and is registered under CIN L65993WB1989PLC047002. Listed on BSE: 533259 and NSE: HEALTHX.
Health X Platform reported revenue of ₹1,319.27 Cr for FY 2025-26 (up 13.9% YoY) based on consolidated financials.
Health X Platform has 6 current directors:
- Banwari Lal Mittal - Managing Director
- Jayanta Nath Mukhopadhyaya - Director
- Ravi Kant Sharma - Director
- Abha Mittal - Director
- Rupanjana De - Director
- Anjana Dikshit - Director
The latest financial statements of Health X Platform on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Health X Platform is 19AADCS7147N1ZP, registered in West Bengal.
The CIN (Corporate Identification Number) of Health X Platform is L65993WB1989PLC047002. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Health X Platform is a listed company as per MCA records. Its shares are listed on both BSE (code: 533259) and NSE (symbol: HEALTHX).
Health X Platform has 21 court cases on record: 21 filed by the company. 2 are pending. Most are in the district courts.
Health X Platform was incorporated on 06 June 1989, making it 37+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Health X Platform by revenue are MGD Holdings Private Limited, BF Investment Limited, KNRC Holdings and Investments Private Limited, Stock Holding Corporation of India Limited, all in the BFSI industry (Healthcare Products, Holding Company), with the same principal business activity (other financial activities).
Parimal Kumar Chattaraj ceased to be Director on 31 Mar 2024. Anjana Dikshit was appointed as Director on 10 Nov 2023. Rajeev Goenka ceased to be Director on 28 Sep 2021. Health X Platform has 37 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
